Calithera Biosciences

$3.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.68%) Today
+$0.05 (+1.68%) As of 10:28 PM UTC after-hours

Why Robinhood?

You can buy or sell CALA and other stocks, options, and ETFs commission-free!

About CALA

Calithera Biosciences, Inc. Common Stock, also called Calithera Biosciences, is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel and critical metabolic pathways in tumor and cancer-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA. The listed name for CALA is Calithera Biosciences, Inc. Common Stock.

CEO
Susan M. Molineaux
Employees
93
Headquarters
South San Francisco, California
Founded
2010
Market Cap
218.00M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.52M
High Today
$3.07
Low Today
$2.94
Open Price
$3.01
Volume
849.78K
52 Week High
$8.18
52 Week Low
$2.46

CALA Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 10, After Hours

You May Also Like

QVCD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure